Aspargo Laboratories is a developer of an oral spray that treats erectile dysfunction.
Aspargo Laboratories has raised $60.0M in total funding. The most recent round was Private Equity. The last funding was announced in March 2022.
Aspargo Laboratories is headquartered in Englewood, United States.
Aspargo Laboratories is a developer of an oral spray that treats erectile dysfunction.
Aspargo Laboratories is at the Private Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aspargo Laboratories — Funding & Investors." VCBacked, March 28, 2022, https://www.vcbacked.co/company/aspargo-laboratories. Accessed August 15, 2026.
VCBacked. (2022). Aspargo Laboratories — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/aspargo-laboratories
{{cite web |title=Aspargo Laboratories — Funding & Investors |url=https://www.vcbacked.co/company/aspargo-laboratories |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated